Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
Clinical trial NCT05766813 · COMPLETED
Trial details
- NCT number
- NCT05766813
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2025-10-28
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.